Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2010
  • Online publication date: October 2010

15 - Clinical aspects of cocaine and methamphetamine dependence

from Part 2 - Real World

References

Anglin, M. D., Burke, C., Perrochet, B., Stamper, E. & Dawud-Noursi, S. (2000). History of the methamphetamine problem. Journal of Psychoactive Drugs, 32(2), 137–41.
Carroll, K. M. (1998). A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, MD: U.S. Department of Health and Human Services.
Carroll, K. M. & Rawson, R. A. (2005). Relapse prevention for stimulant dependence. In Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Disorders, eds. G. A. Marlatt & D. M. Donovan. New York: Guilford Press.
Carroll, K. M., Rounsaville, B. J. & Gawin, F. H. (1991). A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. American Journal of Drug and Alcohol Abuse, 17(3), 229–47.
Carroll, K. M., Nich, C., Ball, S. A., McCance, E. F. & Rounsaville, B. (1998). Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction, 93, 713–28.
Carroll, K. M., Fenton, L. R., Ball, S. A.et al. (2004). Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Archives of General Psychiatry, 61(3), 264–72.
Castells, X., Casas, M., Vidal, X.et al. (2007). Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta-analysis of randomized controlled clinical trials. Addiction, 102(12), 1871–87.
Center for Substance Abuse Treatment. (2006a). Counselor’s Treatment Manual: Matrix Intensive Outpatient Treatment for People with Stimulant Use Disorders. Rockville, MD: Substance Abuse and Mental Health Services Administration.
Center for Substance Abuse Treatment. (2006b). Client’s Handbook: Matrix Intensive Outpatient Treatment for People with Stimulant Use Disorders. Rockville, MD: Substance Abuse and Mental Health Services Administration.
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M. & O’Brien, C. P. (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology, 30(1), 205–11.
Daley, D. C., Mercer, D. & Carpenter, G. (2002). Drug Counseling for Cocaine Addiction: The Collaborative Cocaine Treatment Study Model. National Institute of Health Publication. No. 02–438. Available online at http://www.drugabuse.gov/pdf/Manual4.pdf.
Dodes, L. M. & Khantzian, E. J. (1991). Individual psychodynamic psychotherapy. In Clinical Textbook of Addictive Disorders, eds. R. J. Frances & S. I. Miller. New York: Guilford, pp. 391–405.
Donovan, D. M. & Wells, E. A. (2007). Tweaking 12-step. The potential role of 12-step self-help group involvement in methamphetamine recovery. Addiction, 102(Suppl. 1), 121–9.
Ellis, R. J., Childers, M. E., Cherner, M. et al. (2003). Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases, 12, 1820–6.
Frosch, D., Shoptaw, S., Huber, A. & Ling, W. (1996). Sexual HIV risk among gay and bisexual male methamphetamine users. Journal of Substance Abuse Treatment, 13, 483–6.
Hanson, G. R. & Fleckenstein, A. E. (2009). Basic neuropharmacological mechanisms. In Methamphetamine Addiction: from Basic Science to Treatment, eds. J. M. Roll, R. A. Rawson, W. Ling & S. Shoptaw. New York: Guilford Press, pp. 30–60.
Higgins, S. T., Budney, A. J., Bickel, W. K.et al. (1993). Achieving cocaine abstinence with a behavioral approach. American Journal of Psychiatry, 150, 1218–24.
Iguchi, M. Y., Belding, M. A., Morral, A. R. et al. (1997). Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. Journal of Consulting and Clinical Psychology, 65(3), 421–8.
Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry, 4, 231–44.
Khantzian, E. J., Halliday, K. S. & McAuliffe, W. E. (1990). Addiction and the Vulnerable Self: Modified Dynamic Group Therapy for Substance Abusers. New York: Guilford Press.
King, G. R. & Ellinwood, E. H. (2005). Amphetamines and other stimulants. In Substance Abuse: A Comprehensive Textbook, eds. J. H. Lowinson, P. Ruiz, R. B. Millman & J. G. Langrod. Philadelphia: Lippincott, Williams & Wilkins, pp. 277–302.
Kroutil, L. A., Van Brunt, D. L., Herman-Stahl, M. A.et al. (2006). Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence, 84(2), 135–43.
Landry, M. J. (1992). An overview of cocaethylene: an alcohol-derived, psychoactive, cocaine metabolite. Journal of Psychoactive Drugs, 24(3), 273–6.
Lima, M. S., Soares, B. G., Reisser, A. & Farrell, M. (2002). Pharmacologic treatment of cocaine dependence: a systematic review. Addiction, 8, 931–49.
Marlatt, G. A. & Gordon, J. R. (eds.) (1985). Relapse Prevention. New York: Guilford Press.
McCabe, S. E., Knight, J. R., Teter, C. J. & Wechsler, H. (2005). Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction, 100(1), 96–106.
Mercer, D. E. & Woody, G. E. (1999). An Individual Drug Counseling Approach to Treat Cocaine Addiction: The Collaborative Cocaine Treatment Study Model. Rockville, MD: National Institute on Drug Abuse, NIH Publication Number 99–4380.
Meredith, C. W., Jaffe, C., Ang-Lee, K. & Saxon, A. J. (2005). Implications of chronic methamphetamine use: a literature review. Harvard Review of Psychiatry, 13(3), 141–54.
Miller, W. R., Rollnick, S. (1991). Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford press.
Moeller, F. G., Schmitz, J. M., Herin, D. & Kjome, K. L. (2008). Use of stimulants to treat cocaine and methamphetamine abuse. Current Psychiatry Reports, 10(5), 385–91.
Mooney, L., Glasner-Edwards, S., Rawson, R. A. & Ling, W. (2009). Medical effects of methamphetamine use. In Methamphetamine Addiction: From Basic Science to Treatment, eds J. M. Roll, R. A. Rawson, W. Ling & S. Shoptaw. New York: Guilford Press, pp. 117–42.
Obert, J. L., Rawson, R. A., McCann, M. A. & Ling, W. (1995). Matrix Model Therapist’s Manual: A 16-Week Individualized Program. Center City, MN: Hazelden.
Payer, D. & London, E. D. (2009). Methamphetamine and the brain: findings from brain imaging studies. In Methamphetamine Addiction: from Basic Science to Treatment, eds. J. M. Roll, R. A. Rawson, W. Ling & S. Shoptaw. New York: Guilford Press, pp. 61–91.
Prochaska, J. O., DiClemente, C. C. & Norcross, J. C. (1992). In search of how people change: applications to addictive behaviors. American Psychologist, 47, 1102–14.
Rawson, R. A. (1999). Treatment for Stimulant Use Disorders. Treatment Improvement Protocol Series (TIP) No. 33. DHHS Publication No. (SMA) 99–3296. Rockville, Maryland: U.S. Department of Health and Human Services.
Rawson, R. A., Shoptaw, S. J., McCann, M. J.et al. (1995). An intensive outpatient approach for cocaine abuse treatment: the matrix model. Journal of Substance Abuse Treatment, 12(2), 117–27.
Rawson, R. A., Washton, A. M., Domier, C. P. & Reiber, C. (2002). Drugs and sexual effects: role of drug type and gender. Journal of Substance Abuse Treatment, 22(2), 103–8.
Rutkowski, B. A. & Maxwell, J. C. (2009). Epidemiology of methamphetamine use: a global perspective. In Methamphetamine Addiction: from Basic Science to Treatment, eds. J. M. Roll, R. A. Rawson, W. Ling & S. Shoptaw. New York: Guilford Press, pp. 6–29.
Shearer, J. (2008). The principles of agonist pharmacotherapy for psychostimulant dependence. Drug and Alcohol Review, 27(3), 301–8.
Sheets, M. T. (2003). Quitting Methamphetamine: your Personal Recovery Plan. Center City, MN: Hazelden.
Shoptaw, S., Rawson, R. A., McCann, M. J. & Obert, J. L. (1994). The matrix model of outpatient stimulant abuse treatment: evidence of efficacy. Journal of Addictive Diseases, 13(4), 129–41.
Sofuoglu, M. & Kosten, T. R. (2005). Novel approaches to the treatment of cocaine addiction. CNS Drugs, 19(1), 13–25.
Thompson, P. M., Hayashi, K. M., Simon, S. L.et al. (2004). Structural abnormalities in the brains of human subjects who use methamphetamine. Journal of Neuroscience, 24(26), 6028–36.
Vocci, F. J. & Elkashef, A. (2005). Pharmacotherapy and other treatments for cocaine abuse and dependence. Current Opinions in Psychiatry, 18(3), 265–70.
Vocci, F. J., Elkashef, A. & Appell, N. M. (2009). Pharmacological treatment of methamphetamine addiction. In Methamphetamine Addiction: from Basic Science to Treatment, eds. J. M. Roll, R. A. Rawson, W. Ling & S. Shoptaw. New York: Guilford Press, pp. 202–29.
Washton, A. M. (1987). Cocaine: drug epidemic of the 1980’s. In The Cocaine Crisis, ed. D. Allen. New York: Plenum Press, pp. 45–64.
Washton, A. M. (1988). Preventing relapse to cocaine. Journal of Clinical Psychiatry, 49, 34–8.
Washton, A. M. (1989). Cocaine and compulsive sexuality. Medical Aspects of Human Sexuality, December, 32–9.
Washton, A. M. (2008). Quitting Cocaine: Your Personal Recovery Plan. Center City, MN: Hazelden Foundation.
Washton, A. M. & Gold, M. S. (1986). Crack. Journal of the American Medical Association, 256, 711.
Washton, A. M. & Zweben, J. E. (2006). Treating Alcohol and Drug Problems in Psychotherapy Practice: Doing What Works. New York: Guilford.
Washton, A. M. & Zweben, J. E. (2009). Cocaine and Methamphetamine Addiction: Treatment, Recovery, and Relapse Prevention. New York: Guilford.
Washton, A. M., Gold, M. S. & Pottash, A. C. (1984). Upper-income cocaine abusers. Advances in Alcohol and Substance Abuse, 4(2), 51–7.
Ziedonis, D. M., Rayford, B.S., Bryant, K. J., Rounsaville, B. J. (1994). Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment. Hospital and Community Psychiatry, 45(1), 43–9.
Zweben, J. E., Cohen, J. B., Christian, D.et al. (2004). Psychiatric symptomatology in methamphetamine users. American Journal on Addiction, 13, 181–90.